Availability and cost of major and first-line antiepileptic drugs: a comprehensive evaluation in the capital of Madagascar

BACKGROUND: The prevalence of epilepsy is high in Madagascar (23.5/1000), as is the treatment gap (estimated at 92 %). The health system of the country is underfunded; some AEDs are used, and the national drug policy does not encourage price regulation or the administration of generic agents. We con...

Descripción completa

Detalles Bibliográficos
Autores principales: Jost, Jeremy, Raharivelo, Adeline, Ratsimbazafy, Voa, Nizard, Mandy, Auditeau, Emilie, Newton, Charles R., Preux, Pierre-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053963/
https://www.ncbi.nlm.nih.gov/pubmed/27777862
http://dx.doi.org/10.1186/s40064-016-3409-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053963/
https://www.ncbi.nlm.nih.gov/pubmed/27777862
http://dx.doi.org/10.1186/s40064-016-3409-5

Ejemplares similares